Maze Therapeutics Inc. Revenue 2024–2024
Maze Therapeutics Inc. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Maze Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 20.0 M.
- Maze Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 187.5 M.
- Maze Therapeutics Inc. annual revenue for 2024 was 167.5 M.
Maze Therapeutics Inc. (MAZE) — Frequently Asked Questions
Maze Therapeutics Inc. (MAZE) is a publicly traded US company. It has a market capitalization of $66M. In fiscal 2024 it reported revenue of $168M and net income of $52M. Explore MAZE's stock price, financial statements, earnings history, margins and key ratios below.
What is Maze Therapeutics Inc.'s market cap?
Maze Therapeutics Inc. (MAZE) has a market capitalization of $66M.
What is the MAZE stock price?
MAZE trades at $24.27 (+2.58% on the day).
How much revenue does Maze Therapeutics Inc. make?
Maze Therapeutics Inc. reported revenue of $168M in fiscal 2024.
Is MAZE profitable?
In fiscal 2024, Maze Therapeutics Inc. reported net income of $52M.
What is MAZE's P/E ratio?
Based on diluted EPS, MAZE has a price-to-earnings (P/E) ratio of about 19.4.